Sensorion announces the results of its Combined General Meeting

Montpellier, May 30, 2024 - Sensorion, a biotechnology company specializing in hearing therapies, has made public the results of the Combined General Meeting held on May 29, 2024.

All resolutions proposed by the Board of Directors were adopted. The participation reached 83.6% of the capital.

Detailed voting results are available on the Sensorion website, in the Investors section.

R. H.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based